The radioprotection of salivary glands by vitamin C and sodium bicarbonate in 131I treatment of patients with differentiated thyroid carcinoma

被引：0
|
作者：
Tong, Huimin [1 ]
Gao, Ying [1 ]
Zhang, Xiaomin [1 ]
Li, Xiaoqian [1 ]
Luo, Liping [1 ]
Huang, Nan [1 ]
Hu, Tingting [1 ]
An, Jie [1 ]
Wang, Jin [1 ]
Cheng, Yan [1 ]
机构：
[1] Shanxi Med Univ, First Hosp, Taiyuan, Peoples R China
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1696
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Usefulness of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma at first radioablation
    Garcia-Burillo, A.
    Kisel, N.
    Barios, M.
    Dellepiane, F.
    Gonzalez, J. M.
    Porta, F.
    Obiols, G.
    Castell, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S291 - S291
  • [42] Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma
    Yamamoto, Y
    Nishiyama, Y
    Monden, T
    Matsumura, Y
    Satoh, K
    Ohkawa, M
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (12) : 1905 - 1910
  • [43] Fixed dosage of 131I for remnant ablation in patients with differentiated thyroid carcinoma without pre-ablative diagnostic 131I scintigraphy
    de Klerk, JMH
    de Keizer, B
    Zelissen, PMJ
    Lips, CMJ
    Koppeschaar, HPF
    NUCLEAR MEDICINE COMMUNICATIONS, 2000, 21 (06) : 529 - 532
  • [44] Red marrow and blood dosimetry in 131I treatment of metastatic differentiated thyroid carcinoma: comparison in patients with repeated treatments
    Richetta, E.
    Pasquino, M.
    Cutaia, C.
    Giostra, A.
    Pellerito, R.
    Stasi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S220 - S220
  • [45] Staging of Differentiated Thyroid Carcinoma Using Diagnostic 131I SPECT/CT
    Wong, Ka Kit
    Sisson, James C.
    Koral, Kenneth F.
    Frey, Kirk A.
    Avram, Anca M.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 195 (03) : 730 - 736
  • [46] Iodine biokinetics and 131I absorbed dose in metastatic differentiated thyroid carcinoma
    Liu, Bin
    Kuang, Anren
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [47] Impact of 131I SPECT/CT Imaging on the Management of Differentiated Thyroid Carcinoma
    Vercosa, A. F. A.
    Amorim, B. J.
    Mosci, C.
    Lima, M. C. L.
    Etchebehere, E. C. S. C.
    Santos, A. O.
    Assumpcao, L. V. M.
    Zantut-Wittmann, D. E.
    Ramos, C. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S556 - S557
  • [48] Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma
    Jung-Jun Min
    June-Key Chung
    Yong Lee
    Jae Jeong
    Dong Lee
    Ja Jang
    Myung Lee
    Bo Cho
    European Journal of Nuclear Medicine, 2001, 28 : 639 - 645
  • [49] Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma
    Min, JJ
    Chung, JK
    Lee, YJ
    Jeong, JM
    Lee, DS
    Jang, JJ
    Lee, MC
    Cho, BY
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 639 - 645
  • [50] Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
    Salvatori, M
    Perotti, G
    Rufini, V
    Maussier, ML
    Dottorini, M
    CLINICAL ENDOCRINOLOGY, 2004, 61 (06) : 704 - 710
12345